Your browser doesn't support javascript.
loading
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose.
Bladh, Oscar; Marking, Ulrika; Havervall, Sebastian; Norin, Nina Greilert; Aguilera, Katherina; Hober, Sophia; Smed-Sörensen, Anna; Gordon, Max; Blom, Kim; Åberg, Mikael; Klingström, Jonas; Thålin, Charlotte.
Afiliación
  • Bladh O; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 1882 88 Stockholm, Sweden.
  • Marking U; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 1882 88 Stockholm, Sweden.
  • Havervall S; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 1882 88 Stockholm, Sweden.
  • Norin NG; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 1882 88 Stockholm, Sweden.
  • Aguilera K; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 1882 88 Stockholm, Sweden.
  • Hober S; Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden.
  • Smed-Sörensen A; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Gordon M; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 1882 88 Stockholm, Sweden.
  • Blom K; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 1882 88 Stockholm, Sweden; Public Health Agency of Sweden, Solna, Sweden.
  • Åberg M; Department of Medical Sciences, Clinical Chemistry and SciLifeLab Affinity Proteomics, Uppsala University, Uppsala, Sweden.
  • Klingström J; Public Health Agency of Sweden, Solna, Sweden; Division of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Thålin C; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, 1882 88 Stockholm, Sweden. Electronic address: charlotte.thalin@ki.se.
Lancet Microbe ; 4(7): e488, 2023 07.
Article en En | MEDLINE | ID: mdl-37086736

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: Lancet Microbe Año: 2023 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: Lancet Microbe Año: 2023 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido